welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
New Research Verifies TASINs as Viable Target for Colon Cancer Therapies
A small molecule called TASIN-1 can selectively kill cells with a mutation that is considered to be a precursor to colon cancer, while sparing related normal cells, UT Southwestern Medical Center cancer biologists have demonstrated. The mutated cells that are killed using TASIN-1 are found in more than 80 percent of colon tumors.
The findings could eventually help with both prevention and intervention efforts for colon cancer, which according to the National Cancer Institute is the third most common type of cancer in men and women and the second leading cause of cancer-related mortality in the United States.
expertly curated content related to this topic
-
MUTYH Gene (Protein Coding)Genetic data for MUTYH...
-
Intestinal Tumorigenesis: Mechanisms of Development & ProgressionThis book includes information necessar...
-
Open access to a potential new drug target for bowel cancerThe study, published recently in Develop...
-
Coxib-inhibition of Duodenal Polyp Growth in FAPPreliminary data indicate a protective e...
-
ERβ Expression in Normal, Adenomatous and Carcinomatous Tissues of Patients with Familial Adenomatous PolyposisOBJECTIVES : The APC gene mutation trigg...
-
Gliotoxin Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer CellsThe discovery of new bioactive compounds...
-
The Pathology of Hereditary Polyposis SyndromesOur understanding of the genetics and pa...